| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $4,403,167 ) |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AA031257 | Biomarkers and pathogenesis of Alcoholic acute pancreatitis | 000 | 2 | NIH | 12/9/2024 | $517,938 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01GM141003 | Impact of membrane composition on cholecystokinin receptor structure and function | 000 | 4 | NIH | 12/23/2024 | $415,470 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL161674 | Gender and Asthma | 000 | 3 | NIH | 12/5/2024 | $363,443 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL172784 | Electrically Conductive Stem Cell Derived MicroEngineered Heart Tissue for Regeneration of Injured Myocardium | 000 | 2 | NIH | 1/27/2025 | $605,817 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK130566 | Healing enterocutaneous fistulas using bioengineered biomaterials | 000 | 4 | NIH | 11/18/2024 | $511,541 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K08DK134759 | Aging lymphocytes: senescence programs in lymphocytes relevant to human inflammatory bowel disease | 001 | 3 | NIH | 12/10/2024 | $163,614 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R13DC019564 | International Conference on Advances in Quantitative Laryngology,Voice and Speech Research (AQL) | 000 | 5 | NIH | 2/14/2025 | $4,500 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA271431 | STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22 | 000 | 3 | NIH | 2/13/2025 | $536,076 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI128729 | Mechanisms of IL-33 secretion in allergic diseases | 000 | 9 | NIH | 2/13/2025 | $582,546 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL167811 | Opportunistic Screening for ASCVD using a Multimodal Deep Learning Risk Prediction Model | 000 | 2 | NIH | 11/22/2024 | $615,394 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL162747 | Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair | 000 | 3 | NIH | 11/9/2024 | $652,089 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL133501 | Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure | 000 | 7 | NIH | 11/11/2024 | $409,169 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | UH3CA238926 | HRD-IA signatures in pancreatic ductal adenocarcinoma | 000 | 4 | NIH | 2/14/2025 | $0 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R56AI181754 | Roles of Group 2 Innate Lymphoid Cells in Asthma | 000 | 1 | NIH | 2/14/2025 | $0 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K01NS124911 | Feasibility, Acceptability, and Pilot Testing of a Behavioral Intervention for Chronic Migraine | 001 | 4 | NIH | 2/24/2025 | $147,431 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA289249 | Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer | 000 | 1 | NIH | 3/26/2025 | $0 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K76AG088554 | Genetic architecture of age of onset of amyloid positivity: Integrating imaging and genetic tools to identify novel drivers of disease | 002 | 2 | NIH | 3/27/2025 | $242,999 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK125680 | A randomized control trial of G-POEM for gastroparesis to assess feasibility, safety, efficacy and physiological mechanisms | 000 | 4 | NIH | 1/20/2025 | $0 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01NS127922 | Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma | 001 | 2 | NIH | 1/22/2025 | $118,209 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U54CA274504 | Mathematical Oncology Systems Analysis Imaging Center (MOSAIC) | 000 | 2 | NIH | 11/19/2024 | $0 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R33NS113315 | Biomarker Signature to Predict the Persistence of Post-Traumatic Headache | 001 | 3 | NIH | 11/18/2024 | $0 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | P50CA186781 | Mayo Clinic Multiple Myeloma SPORE | 000 | 9 | NIH | 12/11/2024 | $0 |
| | 2025 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R33NS113315 | Biomarker Signature to Predict the Persistence of Post-Traumatic Headache | 000 | 3 | NIH | 10/1/2024 | -$675,765 |
| | 2025 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL142992 | Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD | 000 | 5 | NIH | 2/20/2025 | $0 |
| | 2025 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA234181 | Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma | 000 | 5 | NIH | 10/29/2024 | $0 |
| | 2025 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R33HL142933 | Increasing Adherence to Pulmonary Rehabilitation after COPD-related Hospitalizations (Transfer) | 003 | 6 | NIH | 12/17/2024 | -$62,654 |
| | 2025 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R37AI071106 | Mechanisms of Allergen-induced Type 2 Immunity | 000 | 16 | NIH | 12/17/2024 | $0 |
| | 2025 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R33HL142933 | Increasing Adherence to Pulmonary Rehabilitation after COPD-related Hospitalizations (Transfer) | 001 | 6 | NIH | 12/10/2024 | $405,362 |
| | 2025 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | P01CA229100 | Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma | 000 | 5 | NIH | 11/5/2024 | $0 |
| | 2025 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL142627 | Myocardial Repair with a Novel Engineered Cardiac Muscle Patch | 000 | 4 | NIH | 10/9/2024 | $0 |
| | 2025 | 2019 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK123138 | Validation of peripheral CGRP signaling as a target for the treatment of pain in chronic pancreatitis | 002 | 2 | NIH | 10/1/2024 | -$280,533 |
| | 2025 | 2019 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK123138 | Validation of peripheral CGRP signaling as a target for the treatment of pain in chronic pancreatitis | 001 | 2 | NIH | 10/1/2024 | -$480,373 |
| | 2025 | 2019 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | RF1AG062110 | Microglial apoE in neuroinflammation and Alzheimer's disease | 000 | 1 | NIH | 10/1/2024 | -$32,603 |
| | 2025 | 2019 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | RF1AG062077 | Novel genetic modifiers of C9orf72 and Tau toxicity | 000 | 2 | NIH | 10/1/2024 | -$356,504 |
|
| Issue Date FY: 2024 ( Subtotal = $28,558,505 ) (Continued on the next page) |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL133501 | Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure | 000 | 6 | NIH | 11/8/2023 | $580,262 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA257558 | Drug eluting injectable biomaterials for next generation chemoembolization | 000 | 4 | NIH | 4/5/2024 | $587,009 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA264048 | Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen | 001 | 4 | NIH | 7/30/2024 | $575,706 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K23AI158813 | Mechanisms of adverse gastrointestinal events during oral immunotherapy | 000 | 3 | NIH | 6/17/2024 | $189,864 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R56AI181754 | Roles of Group 2 Innate Lymphoid Cells in Asthma | 001 | 1 | NIH | 7/24/2024 | -$181,927 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R56AI181754 | Roles of Group 2 Innate Lymphoid Cells in Asthma | 000 | 1 | NIH | 5/3/2024 | $480,218 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | UH3CA238926 | HRD-IA signatures in pancreatic ductal adenocarcinoma | 002 | 4 | NIH | 7/24/2024 | $0 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | UH3CA238926 | HRD-IA signatures in pancreatic ductal adenocarcinoma | 001 | 4 | NIH | 4/18/2024 | $17,221 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | UH3CA238926 | HRD-IA signatures in pancreatic ductal adenocarcinoma | 000 | 4 | NIH | 1/30/2024 | $308,488 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K01NS124911 | Feasibility, Acceptability, and Pilot Testing of a Behavioral Intervention for Chronic Migraine | 001 | 4 | NIH | 9/20/2024 | $240,354 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K01CA230193 | Genetic Literacy and Patient-Caregiver Communication of Prognostic Genetic Technology for Localized Prostate Cancer | 001 | 5 | NIH | 8/13/2024 | $168,264 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL156855 | Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals | 000 | 3 | NIH | 6/18/2024 | $654,653 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K23AG073525 | Neurodegeneration and Neuronal Fluctuations in DLB and AD | 004 | 4 | NIH | 5/20/2024 | $154,324 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI128729 | Mechanisms of IL-33 secretion in allergic diseases | 000 | 8 | NIH | 1/29/2024 | $544,098 |
|
